Avalo Therapeutics
AVTX | NASDAQ
$7.37
-$0.39 (-5.03%)
At close: Nov 16, 2026, 4:00 PM ET
$7.23
-$0.14 (-1.90%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Avalo Therapeutics Statistics
Key statistics explainedMarket Data
$426.16M
$33.34M
0.75
1.5M
55.06M
293.28%
N/A
NASDAQ
US05338F3064
Price Performance
-34.6%
-63.1%
-54.4%
-59.4%
-56.3%
-65.9%
-99.9%
-34.6%
-51.2%
-73.9%
-52.9%
Valuation
-2.55
N/A
0.01
0.04
7,222.99
426.20
0.98
-6.92
-5.32
-6.58
565.14
-0.48
-0.36
-0.54
-39.2%
-14.4%
-18.8%
Financial Health
$392.97M
$153K
$392.97M
$481.43M
16.63
16.63
0.00
-0.00
-0.00
-402.31
0.00
4.94
4
Margins & Profitability
71.2%
-161961.0%
-149861.0%
-150259.3%
-104328.8%
-135867.8%
31539.0%
-30.2%
Returns
-18.4%
-34.2%
-20.9%
-20.9%
-18.8%
Historical Growth (CAGR)
-70.3%
-61.2%
-24.4%
149.3%
78.3%
17.9%
-24.5%
-14.2%
-19.4%
Analyst Forecasts
Buy
7
3.3%
431.1%
Mar 22, 2027
-$0.49
-33.8%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$30.00
307.1%
Cash Flow
$-61.55M
$-61.55M
$-80.16M
-$1.12
-$1.12
-104328.8%
Income Statement
$59K
$42K
$-95.56M
$-92.9M
$-88.65M
-$2.89
$1.79K
$-2.69M
33
Add to Watchlist
Select watchlists to add or remove AVTX